Biocheetah Pte News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BIOCHEETAH ANNOUNCES EXCLUSIVE LICENSING AND COMMERCIALISATION AGREEMENT WITH NIPPON KAYAKU FOR VECanDx(TM) IN JAPAN

BioCheetah Pte. Ltd. (Head Office: Singapore; CEO: Dr. Lee Kian Chung; hereinafter BioCheetah) and Nippon Kayaku Co., Ltd. (Head Office: Tokyo; President: Mr. Atsuhiro Wakumoto; hereinafter Nippon Kayaku) announce that the two companies have

Lee kian chungBiocheetah pteAtsuhiro wakumotoHead officeNippon kayaku co ltdTokyo stock exchangeNippon kayakuEnzyme linked immunosorbent assayPoint of care test

BioCheetah announces exclusive licensing and commercialisation agreement with Nippon Kayaku for VECanDx in Japan

BioCheetah announces exclusive licensing and commercialisation agreement with Nippon Kayaku for VECanDx in Japan
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

Atsuhiro wakumotoLee kian chungBiocheetah pteNippon kayaku co ltdTokyo stock exchangeHead officeNippon kayakuEnzyme linked immunosorbent assayPoint of care test

Papyrus Therapeutics Announces Formation of Scientific Advisory Board

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesFrance generalUppsala lanWest chesterCity ofUnited kingdomRaoul charles coombesJamesb lorensPaul blakeEcole normale superieureR charles coombes fmedsciJim lorensBiocheetah pteJean paul thieryMichaelj birrerBoards of the science for life laboratory